Australasian Dermatology Registry

Australasian Dermatology Registry Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Australasian Dermatology Registry, Medical and health, Melbourne, Melbourne.

The Australasian Dermatology Registry captures real world data to enable monitoring and surveillance of current and emerging treatments and provides a platform for dermatology research, helping dermatologists provide the best care to their patients.

The Australasian Dermatology Registry (ADR) isn’t just a database-it’s a powerful tool for advancing skin health across ...
21/04/2026

The Australasian Dermatology Registry (ADR) isn’t just a database-it’s a powerful tool for advancing skin health across Australia and New Zealand.

With the ADR, clinicians can:
-Review aggregate registry data to see the big picture across populations
-Compare outcomes between different dermatological conditions
-Benchmark individual clinics against the registry cohort
-Track patient outcomes over time and monitor treatment effectiveness

By turning data into actionable insights, the ADR empowers healthcare professionals to improve care, enhance safety, and drive research in dermatology.

We’re thrilled to share that public hospitals across Victoria are now participating in the Australasian Dermatology Regi...
09/04/2026

We’re thrilled to share that public hospitals across Victoria are now participating in the Australasian Dermatology Registry (ADR)!

This means clinicians and patients in Victoria can contribute to vital skin health data, helping improve care and outcomes across the state and beyond.

Participating public hospitals include The Alfred Hospital, Austin Health, Eastern Health, Monash Health, Northern Health, The Royal Children's Hospital, The Royal Melbourne Hospital and St Vincent’s Hospital Melbourne.

By joining the ADR, these hospitals are helping to:
✔ Track patient outcomes
✔ Support cutting-edge dermatology research
✔ Shape the future of skin care in Australasia

Learn more about how ADR is making a difference:
https://australasiandermatologyregistry.org.au/

Congratulations to the Australasian Dermatology Registry (ADR) team on their recent publication ‘Real-World Efficacy and...
13/03/2026

Congratulations to the Australasian Dermatology Registry (ADR) team on their recent publication ‘Real-World Efficacy and Drug Survival of Adalimumab in Australian Patients With Psoriasis’ in the Australasian Journal of Dermatology.

The study evaluated the real-world efficacy and drug survival of Adalimumab for moderate-to-severe chronic plaque psoriasis using data from the Australasian Dermatology Registry. Outcomes from Australian clinical practice were compared with results from the Phase 3 REVEAL trial and its open-label extension.

The findings showed that adalimumab maintained strong effectiveness in real-world practice, with stable PASI90 responses over three years and drug survival of around 28 months. Achieving low disease activity (PASI ≤2) and male s*x were associated with longer treatment persistence, supporting the continued effectiveness of adalimumab in routine psoriasis care.

Check out the publication now via the link below. https://lnkd.in/ghAUcKsx

The ADR is a national collaboration between dermatologists, facilitated by the Skin Health Institute, a centre of excellence committed to best practice patient care.

The Australasian Dermatology Registry is inviting researchers from Australia and New Zealand to utilise registry data fo...
24/02/2026

The Australasian Dermatology Registry is inviting researchers from Australia and New Zealand to utilise registry data for their studies. This real-world evidence helps identify effective treatments, assess quality of care, and understand risk factors that affect outcomes.

De-identified data are available to clinics that contribute, supporting better treatment decisions and improved patient care.

The ADR is a national collaboration between dermatologists, facilitated by the Skin Health Institute, a centre of excellence committed to best practice patient care.

The Australasian Dermatology Registry is conducting a study to determine the two-year drug survival rate of deucravaciti...
17/02/2026

The Australasian Dermatology Registry is conducting a study to determine the two-year drug survival rate of deucravacitinib (Sotyku), an oral TYK2 inhibitor used for treating psoriasis.

While clinical trials have shown deucravacitinib to be effective and safe, real-world data are still limited. This study will help understand the long-term effectiveness, identify factors influencing drug survival, and assess potential adverse events.

📅 Results will be presented at the Australasian College of Dermatologists Annual Scientific Meeting in May 2027.

🔗 Register Your Interest today and contribute to advancing psoriasis treatment: https://australasiandermatologyregistry.org.au/register-your-interest/

This study is proudly funded by Bristol Myers Squibb.

To learn more about the ADR and how to get involved, visit the link below.
https://australasiandermatologyregistry.org.au/

If you’re attending a participating dermatology clinic your clinical team may invite you to take part in the Australasia...
13/02/2026

If you’re attending a participating dermatology clinic your clinical team may invite you to take part in the Australasian Dermatology Registry. You can complete the consent form and questionnaire quickly and easily on your smart device using the QR code or weblink provided.

By joining, you help researchers and dermatologists: • Better understand real-world treatment outcomes • Identify risks and benefits of current and emerging therapies • Improve care for people with skin conditions across Australia • Contribute to meaningful national and international research

Participation is fully voluntary, and you can change your mind at any time. Your information is encrypted and securely protected.

Your participation helps drive better patient outcomes and gives your clinic access to up-to-date registry analyses and ...
08/02/2026

Your participation helps drive better patient outcomes and gives your clinic access to up-to-date registry analyses and personalised clinic-level reports - so you can see how your cohort compares across the registry.

Dermatologists who contribute data and review registry reports are eligible to claim Category 3 CPD for these activities.

Ready to get involved? 📩 Contact the registry team to become a participating site.

The ACD CPD program encourages lifelong learning, helping you identify knowledge gaps and upskill. Active involvement in...
29/01/2026

The ACD CPD program encourages lifelong learning, helping you identify knowledge gaps and upskill. Active involvement in the Registry can earn dermatologists Category 2 and 3 CPD hours.

✔️ Category 2: Self-reflection – Evaluating your practices to improve future performance.
✔️ Category 3: Registry Involvement – Analysing data, reviewing documentation, and assessing patient outcomes.

Your involvement in the registry is a meaningful way to provide the best care for people with skin conditions.

The ADR is a national collaboration between dermatologists, facilitated by the Skin Health Institute, a centre of excellence committed to best practice patient care.

Clinical registries play a crucial role in improving healthcare quality. By collecting key data, registries help dermato...
23/01/2026

Clinical registries play a crucial role in improving healthcare quality. By collecting key data, registries help dermatologists and other health professionals provide the best care for those with skin conditions. The Australasian Dermatology Registry serves as a valuable resource for advancing dermatology research.

The insights gained can:
✔️ Identify risk factors
✔️ Assess the impact on quality of life
✔️ Evaluate treatment effectiveness
✔️ Monitor side effects

The ADR is a national collaboration between dermatologists, facilitated by the Skin Health Institute, a centre of excellence committed to best practice patient care.

Clinical registries help us see the bigger picture. By collecting real-world data from people living with specific condi...
13/01/2026

Clinical registries help us see the bigger picture.

By collecting real-world data from people living with specific conditions, they help track outcomes, monitor quality of care, and guide evidence-based decisions.

For clinicians and researchers, registries reveal trends, improve safety, and support best practice.

For patients, they amplify real experiences to shape policy, improve care, and fuel medical research.

Together, we’re building a smarter, learning healthcare system.

The Australasian Dermatology Registry (ADR) is growing with 85 clinics participating and more joining every day.By takin...
25/11/2025

The Australasian Dermatology Registry (ADR) is growing with 85 clinics participating and more joining every day.

By taking part, you're helping to improve care, support research, and better understand skin conditions across Australia.

💬 Ask your dermatologist if your clinic is involved.

📍 Visit our website via the link in bio to see all participating sites and find out how to join.

The Australasian Dermatology Registry is helping transform the way we understand skin health across Australia.By capturi...
20/11/2025

The Australasian Dermatology Registry is helping transform the way we understand skin health across Australia.

By capturing real-world data on psoriasis, atopic dermatitis (eczema), hidradenitis suppurativa, and vitiligo, the registry provides powerful insights into how these conditions impact people of all ages and backgrounds.

This information helps clinicians track trends, improve treatment outcomes, support research, and ultimately deliver better care for patients living with chronic skin disease.

Better data means better dermatology.


Address

Melbourne
Melbourne

Alerts

Be the first to know and let us send you an email when Australasian Dermatology Registry posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Australasian Dermatology Registry:

Share